• InnovAge reaffirmed fiscal 2027 adjusted EBITDA guidance of $105 million to $115 million, with revenue projected at $1.05 billion to $1.09 billion.
• Ending census is expected to reach 8,625 to 8,850 participants, compared with 8,420 at September 30, 2026.
• Medicare rates are expected to rise 1.5% to 2% effective January 1, including the anticipated impact of the V28 risk-adjustment transition.
• First-quarter adjusted EBITDA rose to $31.3 million from $17.6 million a year earlier; revenue increased 12.1% to $264.8 million.
• The outlook reflects expected seasonal moderation following the typically strongest first quarter, with higher labor costs taking full effect in the second quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InnovAge Holding Corporation published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.